Skip to content

GSK PLC

GSK· NYSECore metricsCIK 1131399

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · +0.06%
Market cap
—
no share count on file
Filings
1,080
£32.67B
FY 2025+4.1% FY25 yoy
£5.72B
FY 2025+122.0% FY25 yoy
£7.93B
FY 2025+97.3% FY25 yoy
£6.39B
FY 2025derived+24.0% FY25 yoy
£1.39
FY 2025+123.2% FY25 yoy
£3.40B
FY 2025−12.2% FY25 yoy

Price

$50.63+4.59%+$2.22past year
Nov 12, 2026 · IEX last sale
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

£32.67BFY 2025
£33.75B0FY 2015FY 2020FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31£32,667,000,000reported
FY 20242024-12-31£31,376,000,000reported
FY 20232023-12-31£30,328,000,000reported
FY 20222022-12-31£29,324,000,000reported
FY 20212021-12-31£24,696,000,000 revisedreported
FY 20202020-12-31£24,354,000,000 revisedreported
FY 20192019-12-31£33,754,000,000reported
FY 20182018-12-31£30,821,000,000reported
FY 20172017-12-31£30,186,000,000reported
FY 20162016-12-31£27,889,000,000reported
FY 20152015-12-31£23,923,000,000reported

Capital returns

Dividends and buybacks · FY2016 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025£2.56B£1.38B£3.94B$0.664.32B sh+0.0%61.6%
FY2024£2.44B£0.00£2.44B$0.614.31B sh+0.1%47.4%
FY2023£2.25B£0.00£2.25B$0.584.31B sh+0.0%41.2%
FY2022£3.47B—£3.47B$0.614.31B sh−20.0%55.4%
FY2021£4.00B—£4.00B$1.005.39B sh+0.0%57.1%

Segments

Revenue by Segments, FY2018 to FY2023FY2018Consumer Healthcare · FY2018 · £7.66BPharmaceuticals · FY2018 · £17.27BVaccines · FY2018 · £5.89BFY2019Consumer Healthcare · FY2019 · £9.00BPharmaceuticals · FY2019 · £17.55BVaccines · FY2019 · £7.16BFY2020Commercial Operations · FY2020 · £24.23BConsumer Healthcare · FY2020 · £122.00MPharmaceuticals · FY2020 · £17.06BVaccines · FY2020 · £6.98BFY2021Commercial Operations · FY2021 · £24.70BPharmaceuticals · FY2021 · £17.73BVaccines · FY2021 · £6.78BFY2022Commercial Operations · FY2022 · £29.32BFY2023Commercial Operations · FY2023 · £30.33B
LineFY2023ShareChange
Commercial Operations£30.33B100%+3.4%
Consumer Healthcare———
Pharmaceuticals———
Vaccines———
Total£30.33B

From the 20-F filed Mar 5, 2024GSK

Pharmaceutical preparations

553 covered companies are filed under this code. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, largest by revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

GSK PLC · CIK 1131399 · Engraved from SEC EDGAR